|
[1]
|
薛姣姣, 胡海, 刘磊. 超声评估糖尿病足溃疡合并感染的微循环变化及其与多重耐药菌感染的相关性[J]. 中国病原生物学杂志, 2025, 20(11): 1438-1443.
|
|
[2]
|
龚秀娥, 张小燕, 王博. 神经外科住院患者肺部多重耐药菌感染危险因素分析及集束化护理干预策略研究[J]. 中国病原生物学杂志, 2025, 20(11): 1408-1413.
|
|
[3]
|
路旭, 柯尊钰, 周悦, 等. 神经内科颅内感染多重耐药菌分布情况及影响因素调查[J]. 中国病原生物学杂志, 2025, 20(9): 1189-1193.
|
|
[4]
|
唐梦琦, 于茜, 沙珍萍, 等. 基于倾向指数匹配的ICU多重耐药菌医院感染经济负担评价[J]. 中华医院感染学杂志, 2025, 35(21): 3227-3231.
|
|
[5]
|
张艾, 朱欢. 基于DRGs的多重耐药菌医院感染监测及其经济负担评价[J]. 中华医院感染学杂志, 2025, 35(21): 3211-3215.
|
|
[6]
|
王琳, 屈妍. 多重耐药菌医院感染防控研究进展[J]. 中国防痨杂志, 2025, 47(9): 1196-1203.
|
|
[7]
|
石丽丽, 牛永祝, 张秀娟, 等. 医院多重耐药菌感染防控评价指标体系的构建与实证研究[J]. 现代预防医学, 2025, 52(13): 2471-2476+2490.
|
|
[8]
|
单娇, 怀伟, 孟珊珊, 等. 基于全球医院感染暴发数据库探讨烧伤患者多重耐药菌医院感染暴发流行特征及防控策略[J]. 中华医院感染学杂志, 2025, 35(17): 2592-2596.
|
|
[9]
|
Schaumburg, T., Köhler, N., Breitenstein, Y., Kolbe-Busch, S., Hasenclever, D. and Chaberny, I.F. (2025) Publisher Correction: EFFECT of Daily Antiseptic Bathing with Octenidine on ICU-Acquired Bacteremia and ICU-Acquired Multidrug-Resistant Organisms: A Multicenter, Cluster-Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study. Intensive Care Medicine, 51, 833-833. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Schaumburg, T., Köhler, N., Breitenstein, Y., Kolbe-Busch, S., Hasenclever, D. and Chaberny, I.F. (2024) EFFECT of Daily Antiseptic Bathing with Octenidine on ICU-Acquired Bacteremia and ICU-Acquired Multidrug-Resistant Organisms: A Multicenter, Cluster-Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study. Intensive Care Medicine, 50, 2073-2082. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
王忠礼, 宋红升, 雷琪, 等. 神经内科颅内感染性疾病患者多重耐药菌感染危险因素分析[J]. 中国医院药学杂志, 2024, 44(18): 2135-2140.
|
|
[12]
|
宋红升, 王忠礼, 王宇萍. 国内ICU多重耐药菌感染患者的疾病负担Meta分析[J]. 中国抗生素杂志, 2024, 49(4): 427-437.
|
|
[13]
|
Yang, S., Sun, Y., Wang, T., Hao, C., Zhang, H., Sun, W., et al. (2025) Machine Learning-Based Prediction of Mortality and Multidrug-Resistant Infection Risks in ICU Patients with Suspected Infection: A Prospective National Multicenter Cohort Study. BMC Infectious Diseases. [Google Scholar] [CrossRef]
|
|
[14]
|
Umer, M., Jagra, A.S., Hanif, F.M., Khan, M. and Sharma, H. (2025) Seven Days versus Extended Duration Antibiotic Therapy for Multidrug-Resistant Gram-Negative Bacterial Infections in Critically Ill Patients: A Pooled Analysis of the OPTIMISE and REGARD-VAP Trials. Journal of Critical Care, 92, Article 155361. [Google Scholar] [CrossRef]
|
|
[15]
|
Falagas, M.E., Kontogiannis, D.S., Romanos, L.T., Ragias, D., Agoranou, M.E. and Kakoullis, S.A. (2025) Intravenous Fosfomycin for Gram-Negative and Gram-Positive Bacterial Infections: A Systematic Review of the Clinical Evidence. Antibiotics, 14, Article 1193. [Google Scholar] [CrossRef]
|